A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
Common vaccines for infectious diseases have been repurposed as cancer immunotherapies. The intratumoral administration of these repurposed vaccines can induce immune cell infiltration into the treated tumor. Here, we have used an approved trivalent live attenuated measles, mumps, and rubella (MMR)...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cell Press
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |